For help on how to get the results you want, see our search tips.
9 results
Medicine
Opinions on maximum residue limits Remove Opinions on maximum residue limits filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Summaries of opinion Remove Summaries of opinion filter
Medicine type
Additional monitoring Remove Additional monitoring filter
Accelerated assessment Remove Accelerated assessment filter
Generic Remove Generic filter
Application type
Initial authorisation Remove Initial authorisation filter
-
List item
Summary of opinion: Sapropterin Dipharma
sapropterin, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Sitagliptin / Metformin hydrochloride Mylan
metformin hydrochloride, sitagliptin hydrochloride monohydrate, opinion date: 16/12/2021, Positive, Last updated: 17/12/2021 -
List item
Summary of opinion: Rybrevant
amivantamab, opinion date: 14/10/2021, Positive, Last updated: 15/10/2021 -
List item
Summary of opinion: Lumykras
sotorasib, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Lonapegsomatropin Ascendis Pharma
lonapegsomatropin, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Wegovy
semaglutide, opinion date: 11/11/2021, Positive, Last updated: 12/11/2021 -
List item
Summary of opinion: Dasatinib Accord (new)
dasatinib, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Dasatinib Accordpharma (new)
dasatinib, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022 -
List item
Summary of opinion: Vildagliptin / Metformin hydrochloride Accord (new)
vildagliptin / metformin hydrochloride, opinion date: 27/01/2022, Positive, Last updated: 28/01/2022